NCT02926560

Brief Summary

The aim of this study is 1\) To describe the level and determinants of methotrexate adherence in patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) in the department of rheumatology in the Nîmes University Hospital

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2016

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 6, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2018

Completed
Last Updated

January 14, 2019

Status Verified

January 1, 2019

Enrollment Period

2 years

First QC Date

September 16, 2016

Last Update Submit

January 11, 2019

Conditions

Rheumatic Diseases

Keywords

Chronic inflammatory rheumatism

Outcome Measures

Primary Outcomes (1)

  • Medication Adherence Measure= Morisky scale

    day 0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) treated by methotrexate in the department of rheumatology in the Nîmes University Hospital

You may qualify if:

  • treated by methotrexate
  • patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis)

You may not qualify if:

  • methotrexate for other diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Nîmes

Nîmes, Gard, 30000, France

Location

MeSH Terms

Conditions

Rheumatic Diseases

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Cécile Gaujoux-Viala, MD,PhD

    CHU Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2016

First Posted

October 6, 2016

Study Start

June 1, 2016

Primary Completion

May 30, 2018

Study Completion

May 30, 2018

Last Updated

January 14, 2019

Record last verified: 2019-01

Locations

FR(1)